Dr. Yang Yu 俞洋
Chief Physician
Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and minimally invasive treatment of breast diseases, early diagnosis and treatment of breast cancer, sentinel lymph node biopsy, and breast reconstruction.
Dr. Yu holds a Master of Surgery degree. Dr. Yu graduated from Xiangya School of Medicine, Central South University, in 1998 and completed a three-month advanced study program in Germany in 2011.
Professional roles
- Member, Epidemiology Professional Committee, Zhejiang Anti-Cancer Association
- Member, Pediatric Surgery Professional Committee, Zhejiang Medical Association
- Standing Committee Member, Breast Professional Committee (Zhejiang Branch), Zhejiang Medical Education Association
- Member, Biomaterials Group, China International Exchange and Promotion Association for Medicine and Healthcare
Name order: in Chinese the family name comes first (Yu Yang). Papers usually list the name as Yang Yu or Yu Y.
Selected publications
47 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Postgrad Med J, 2025 (senior author): Roles of macrophages and monocytes in resistance to immunotherapy in breast cancers. PubMed 40327894
- Mol Cell Biochem, 2025 (senior author): Ferroptosis in TNBC: interplay with tumor-infiltrating immune cells and therapeutic implications. PubMed 40439838
- Cancer Manag Res, 2024 (senior author): Oncoplastic Breast-Conserving Surgery for Upper Inner Quadrant Breast Cancer Using Pedicled Pectoralis Major Myofascial Flap. PubMed 39678040
- Front Pharmacol, 2023 (senior author): Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment. PubMed 37521475
- JAMA Oncol, 2022 (first author): Clinical Utility Assessment of Gonadotropin-Releasing Hormone Analogs Among Women Younger Than 35 Years-Reply. PubMed 35420636
- Cancer Manag Res, 2021 (senior author): The Guiding Significance of the Number of Positive Sentinel Lymph Nodes in Frozen Section for Intraoperative Axillary Dissection in Early Breast Cancer. PubMed 34168499
- Cancer Manag Res, 2021 (senior author): Dissection of Level III Axillary Lymph Nodes in Breast Cancer. PubMed 33664591
- Cancer Biol Ther, 2020 (senior author): The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience. PubMed 32420815
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion